Cargando...
The role of third‐generation beta‐blocking agents in chronic heart failure
Third‐generation beta‐blocking agents developed for the hypertension market are proving useful in the treatment of chronic heart failure (HF). These compounds share the ancillary property of vasodilation, which improves acute tolerability by unloading the failing left ventricle at a time when beta‐a...
Gardado en:
| Publicado en: | Clin Cardiol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley Periodicals, Inc.
2009
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6656140/ https://ncbi.nlm.nih.gov/pubmed/9853189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960211303 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|